Remdesivir

Clinical trials have shown the drug cuts the duration of symptoms, but there's previously been no data on survival.
As US buys up worlds supplies of Remdesivir, UK calls for more "collaboration".
Trials found that the anti-viral drug can reduce the recovery time of Covid-19 patients by four days.
The FDA issued emergency approval for the medicine, which may help hospitalized COVID-19 patients recover.
Interest in Gileads remdesivir has been high as there are currently no approved treatments or preventive vaccines for COVID-19.